Imatinib Recruiting Phase 2 Trials for Chronic Myeloid Leukemia (CML) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03193281KISS Study: Kinase Inhibition With Sprycel Start up